- Presentations
- 2
- Markets
- 1
Exondys 51 is a brand of Eteplirsen marketed by Sarepta Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Eteplirsen
- Brand owner
- Sarepta Therapeutics
- Registered in
- United States
- Strengths and forms
- 100 mg/2 mL injection, 500 mg/10 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Exondys 51 100 mg/2 mL injectionIntravenous Cold chain | Sarepta Therapeutics | US FDA | Available on request |
| Exondys 51 500 mg/10 mL injectionIntravenous Cold chain | Sarepta Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Exondys 51
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.